Please login to the form below
Smart Thinking blog
Insights and expert advice on the key issues facing today’s pharma marketer
Is it a commitment issue?
Trust me I'm in advertising07 May 2013
How does healthcare advertising's repute fare in online open forums?
Team Gold22 Apr 2013
Putting a best practice sharing model in place
The incredible journey: multichannel communications with HCPs09 Apr 2013
Management tools to optimise multichannel communications with HCPs
How robust is your targeting?18 Mar 2013
Should we be targeting customers on what they have done in the past, or what they think they will do in the future?
Letting the patient voice be heard13 Mar 2013
How well is your campaign really reflecting patient insights – or is it more about what you or their HCPs want them to hear?
Keying in loyalty04 Mar 2013
Why you need to put return on engagement (RoE) above all else
Social innovation in pharma18 Feb 2013
The use of social media by pharma beyond Facebook and Twitter
Building brand strength – Part 414 Feb 2013
Commitment, responsiveness and protection – how far will Big Pharma go to preserve its brands?
- Iconic Brands Survey: The results
07 Feb 2013
What did you vote as the most iconic brand in pharma?
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Global biosimilars market to reach $2.45bn in 2013
- Bringing trial data out of the shadows
- Novartis gets FDA green light for new Ilaris indication
- Brazil eHealth pilot improves healthcare access for city poor
- Amgen and Novartis partner with biotech venture capital firm
- Death leads to recall of batch of Takeda's Rienso in Switzerland
- Astellas gets first OK for prostate drug Vesomni
- Edelman appoints Red Health's Paul Gittins
- Merck & Co inches closer to US green light for insomnia drug
- GSK awarded $200m by US government for antibiotic research
- Clinical trial regulation in Mexico
PMHub
Add my companySynergy Vision
Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma ...
Latest intelligence
- Clinical trial regulation in Mexico
- Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing...
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
Quick links
